B. Riley Predicts Abacus Life’s Q1 Earnings (NASDAQ:ABL)

Abacus Life, Inc. (NASDAQ:ABLFree Report) – Equities researchers at B. Riley cut their Q1 2025 earnings per share (EPS) estimates for shares of Abacus Life in a report issued on Wednesday, April 9th. B. Riley analyst R. Binner now anticipates that the company will post earnings of $0.14 per share for the quarter, down from their previous forecast of $0.15. B. Riley has a “Buy” rating and a $15.00 price objective on the stock. The consensus estimate for Abacus Life’s current full-year earnings is $0.62 per share. B. Riley also issued estimates for Abacus Life’s Q2 2025 earnings at $0.16 EPS and Q4 2025 earnings at $0.26 EPS.

Abacus Life (NASDAQ:ABLGet Free Report) last released its earnings results on Thursday, March 27th. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.13 by $0.03. The firm had revenue of $33.21 million during the quarter, compared to analysts’ expectations of $28.76 million. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%.

Separately, Piper Sandler lowered their price target on Abacus Life from $13.00 to $11.50 and set an “overweight” rating on the stock in a research note on Tuesday. Five analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $14.00.

Read Our Latest Report on Abacus Life

Abacus Life Stock Performance

NASDAQ:ABL opened at $7.13 on Thursday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.29 and a current ratio of 1.29. The firm’s 50-day moving average is $7.49 and its 200-day moving average is $8.07. Abacus Life has a 52-week low of $6.34 and a 52-week high of $12.50. The company has a market cap of $690.56 million, a price-to-earnings ratio of -39.61 and a beta of 0.16.

Hedge Funds Weigh In On Abacus Life

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Geneos Wealth Management Inc. acquired a new position in Abacus Life in the fourth quarter valued at about $110,000. Squarepoint Ops LLC bought a new position in shares of Abacus Life in the fourth quarter valued at approximately $113,000. JPMorgan Chase & Co. boosted its holdings in shares of Abacus Life by 640.9% in the 4th quarter. JPMorgan Chase & Co. now owns 16,670 shares of the company’s stock worth $131,000 after acquiring an additional 14,420 shares in the last quarter. LPL Financial LLC grew its position in Abacus Life by 31.0% during the 4th quarter. LPL Financial LLC now owns 23,288 shares of the company’s stock worth $182,000 after acquiring an additional 5,507 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in Abacus Life during the 4th quarter valued at $193,000.

About Abacus Life

(Get Free Report)

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.

See Also

Earnings History and Estimates for Abacus Life (NASDAQ:ABL)

Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.